RSLS Live-Signale | Maximieren Sie Profite mit Getagraph.com

KAUFEN 119694 min ago

@ $0.190

Ausgestellt: 6 Feb 2024 @ 17:13

Rendite: -14.84%

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 21:02):

Stats
Tagesvolumen	263 563
Durchschnittsvolumen	496 482
Marktkapitalisierung	3.80M
EPS	$-0.110 ( 2024-04-15 )
Nächstes Ertragsdatum	( $-0.160 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0800
ATR14	$0.00200 (1.24%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-05	Schneid Yair	Sell	0	Common Stock
2023-08-04	Stankovich Thomas	Sell	108	Common Stock, $0.001 par value per share
2023-08-24	Stankovich Thomas	Sell	39	Common Stock, $0.001 par value per share
2023-09-01	Stankovich Thomas	Sell	118	Common Stock, $0.001 par value per share
2023-10-11	Stankovich Thomas	Sell	39	Common Stock, $0.001 par value per share

INSIDER POWER
-2.87
Last 95 transactions
Buy: 10 386 223 \| Sell: 2 711 639

Volumen Korrelation

Lang: -0.02 (neutral)

Kurz: 0.87 (strong)

Signal:(42.156) Same movement expected

ReShape Lifesciences Inc Korrelation

10 Am meisten positiv korreliert
PAIC	0.919
TLGT	0.884
SVAC	0.883
RMRM	0.881
BGFV	0.877
SPRT	0.876
AFMD	0.873
BIOC	0.873
GRNV	0.87
ALIM	0.87

10 Am meisten negativ korreliert
NETE	-0.922
AMRB	-0.906
RAVN	-0.893
BOCH	-0.882
LSCC	-0.88
LSTR	-0.876
MMAC	-0.872
PDFS	-0.868
USLM	-0.864
RNLC	-0.863

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

ReShape Lifesciences Inc Korrelation - Währung/Rohstoff

-0.34
( neutral )

-0.66
( moderate negative )

0.00
( neutral )

0.41
( neutral )

ReShape Lifesciences Inc Finanzdaten

Annual	2023
Umsatz:	$8.68M
Bruttogewinn:	$5.55M (63.93 %)
EPS:	$-1.910

FY	2023
Umsatz:	$8.68M
Bruttogewinn:	$5.55M (63.93 %)
EPS:	$-1.910

FY	2022
Umsatz:	$11.24M
Bruttogewinn:	$6.80M (60.52 %)
EPS:	$-108.90

FY	2021
Umsatz:	$13.60M
Bruttogewinn:	$8.35M (61.38 %)
EPS:	$-250.16

Financial Reports:

No articles found.

ReShape Lifesciences Inc

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.